Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: The benefits of hypofractionated over conventionally fractionated radiotherapy

Canadian Journal of Urology

Volumn 19, Issue 2, 2012, Pages 6165-6169

  Sethukavalan, Perakaa ^a   Cheung, Patrick ^a,b   Tang, Colin I ^c,d   Quon, Harvey ^a,b   Morton, Gerard ^a,b   Nam, Robert ^a,b   Andrew Loblaw, D ^a,b  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Hypofractionation; Patient costs; Prostate cancer; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; COST; COST OF ILLNESS; ECONOMICS; HEALTH CARE DELIVERY; HUMAN; MALE; MIDDLE AGED; PROSTATE TUMOR; RADIATION DOSE FRACTIONATION; TRAFFIC AND TRANSPORT;

ADULT; AGED; AGED, 80 AND OVER; CANADA; COST OF ILLNESS; COSTS AND COST ANALYSIS; DOSE FRACTIONATION; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; TRANSPORTATION;

EID: 84865823863     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Canadian Cancer Society's Steering Committee on Cancer Statistics. Canadian cancer statistics 2011. Toronto, ON: Canadian Cancer Society; 2011.
2. Quon H, Loblaw DA, Nam R. Dramatic increase in prostate cancer cases by 2021. BJU Int 2011;108(11):1734-1738.
3. Tang CI, Loblaw DA, Cheung P et al. Phase I/II study of a fivefraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3. Clin Oncol (R Coll Radiol) 2008;20(10):729-737.
4. Quon H, Loblaw DA, Cheung P, et al. Prospective study of extreme hypofractionated radiotherapy (35 Gy in five fractions) for localized low-risk prostate cancer: toxicity results. Radioth & Oncol 2010;96:S46.
5. Quon H, Cheung PC, Loblaw DA, et al. Hypofractionated concomitant intensity-modulated radiotherapy boost for highrisk prostate cancer: late toxicity. Int J Radiat Oncol Biol Phys 2012; 82(2):898-905.
6. Morton GC, Loblaw DA, Sankreacha R et al. Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life. Int J Radiat Oncol Biol Phys 2010;77(3):811-817.
7. nd, 2011.